DK2509609T3 - Forbedrede fremgangsmåder og sammensætninger for venehøst og autotransplantation - Google Patents

Forbedrede fremgangsmåder og sammensætninger for venehøst og autotransplantation

Info

Publication number
DK2509609T3
DK2509609T3 DK10807761.1T DK10807761T DK2509609T3 DK 2509609 T3 DK2509609 T3 DK 2509609T3 DK 10807761 T DK10807761 T DK 10807761T DK 2509609 T3 DK2509609 T3 DK 2509609T3
Authority
DK
Denmark
Prior art keywords
vene
harvesting
compositions
improved procedures
auto transplantation
Prior art date
Application number
DK10807761.1T
Other languages
English (en)
Inventor
Colleen Brophy
Padmini Komalavilas
Joyce Cheung-Flynn
Kyle Hocking
Susan Eagle
Original Assignee
Univ Vanderbilt
Us Dept Veterans Affairs
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Vanderbilt, Us Dept Veterans Affairs filed Critical Univ Vanderbilt
Application granted granted Critical
Publication of DK2509609T3 publication Critical patent/DK2509609T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/14—Mechanical aspects of preservation; Apparatus or containers therefor
    • A01N1/142—Apparatus
    • A01N1/143—Apparatus for organ perfusion
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/16—Physical preservation processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/02—Access sites
    • A61M39/06—Haemostasis valves, i.e. gaskets sealing around a needle, catheter or the like, closing on removal thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Environmental Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Cardiology (AREA)
  • Surgery (AREA)
  • Diabetes (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Materials For Medical Uses (AREA)
  • Biophysics (AREA)
  • Physiology (AREA)
  • Compounds Of Unknown Constitution (AREA)
DK10807761.1T 2009-12-08 2010-12-08 Forbedrede fremgangsmåder og sammensætninger for venehøst og autotransplantation DK2509609T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26764009P 2009-12-08 2009-12-08
PCT/US2010/059459 WO2011072012A2 (en) 2009-12-08 2010-12-08 Improved methods and compositions for vein harvest and autografting

Publications (1)

Publication Number Publication Date
DK2509609T3 true DK2509609T3 (da) 2014-11-10

Family

ID=43902575

Family Applications (2)

Application Number Title Priority Date Filing Date
DK10807761.1T DK2509609T3 (da) 2009-12-08 2010-12-08 Forbedrede fremgangsmåder og sammensætninger for venehøst og autotransplantation
DK14181978.9T DK2848256T3 (da) 2009-12-08 2010-12-08 Forbedrede fremgangsmåder og sammensætninger til venehøst og autotransplantation

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK14181978.9T DK2848256T3 (da) 2009-12-08 2010-12-08 Forbedrede fremgangsmåder og sammensætninger til venehøst og autotransplantation

Country Status (10)

Country Link
US (3) US8691556B2 (da)
EP (2) EP2848256B1 (da)
JP (2) JP5819846B2 (da)
CN (2) CN104623665B (da)
AU (1) AU2010328203B2 (da)
CA (1) CA2783236C (da)
DK (2) DK2509609T3 (da)
ES (2) ES2710522T3 (da)
SG (1) SG182261A1 (da)
WO (1) WO2011072012A2 (da)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8409846B2 (en) 1997-09-23 2013-04-02 The United States Of America As Represented By The Department Of Veteran Affairs Compositions, methods and devices for maintaining an organ
NZ591524A (en) 2004-10-07 2012-09-28 Transmedics Inc Method for timing pulsatile flow of normothermic perfusate to the heart in ex-vivo organ care
US9301519B2 (en) 2004-10-07 2016-04-05 Transmedics, Inc. Systems and methods for ex-vivo organ care
US8304181B2 (en) 2004-10-07 2012-11-06 Transmedics, Inc. Method for ex-vivo organ care and for using lactate as an indication of donor organ status
US12010987B2 (en) 2004-10-07 2024-06-18 Transmedics, Inc. Systems and methods for ex-vivo organ care and for using lactate as an indication of donor organ status
US9078428B2 (en) 2005-06-28 2015-07-14 Transmedics, Inc. Systems, methods, compositions and solutions for perfusing an organ
US9457179B2 (en) 2007-03-20 2016-10-04 Transmedics, Inc. Systems for monitoring and applying electrical currents in an organ perfusion system
US8420380B2 (en) 2008-01-31 2013-04-16 Transmedics, Inc. Systems and methods for ex vivo lung care
US10070888B2 (en) 2008-10-03 2018-09-11 Femasys, Inc. Methods and devices for sonographic imaging
US9554826B2 (en) 2008-10-03 2017-01-31 Femasys, Inc. Contrast agent injection system for sonographic imaging
US12171463B2 (en) 2008-10-03 2024-12-24 Femasys Inc. Contrast agent generation and injection system for sonographic imaging
EP2637580B1 (en) * 2010-11-09 2017-02-01 Femasys Inc. Devices for managing fluid pressure
EP2704560B1 (en) 2011-04-14 2022-04-06 Transmedics, Inc. Organ care solution for ex-vivo machine perfusion of donor lungs
US9173718B2 (en) * 2013-03-27 2015-11-03 Terumo Cardiovascular Systems Corporation Blood vessel marking system
WO2014182601A1 (en) 2013-05-08 2014-11-13 Children's Medical Center Corporation A method of preventing and treating type 1 diabetes, allograft rejection and lung fibrosis (by targeting the atp/p2x7r axis)
WO2015051336A1 (en) 2013-10-03 2015-04-09 David Wise Compositions and methods for treating pelvic pain and other conditions
US10076112B2 (en) 2014-06-02 2018-09-18 Transmedic, Inc. Ex vivo organ care system
WO2016090498A1 (en) 2014-12-12 2016-06-16 Freed Darren Apparatus and method for organ perfusion
US20180290979A1 (en) * 2015-04-30 2018-10-11 Kyoto University Composition having compound accelerating phosphorylation of ampk as effective component
EP3347084B1 (en) 2015-09-09 2020-11-11 Transmedics, Inc. Aortic cannula for ex vivo organ care system
CA3025673A1 (en) 2016-05-30 2017-12-07 Tevosol, Inc. Apparatus and method for ex vivo lung ventilation with a varying exterior pressure
US11628239B2 (en) 2016-11-04 2023-04-18 University Of Delaware Method for protecting skeletonized blood vessels
US10687793B2 (en) 2017-07-18 2020-06-23 Obp Medical Corporation Minimally invasive no touch (MINT) procedure for harvesting the great saphenous vein (GSV) and venous hydrodissector and retractor for use during the MINT procedure
CN107912419A (zh) * 2017-10-11 2018-04-17 重庆金时代生物技术有限公司 一种人外周血单个核细胞的冻存液及冻存方法
JP7036670B2 (ja) * 2018-05-31 2022-03-15 アークレイ株式会社 血液中の稀少細胞検査、該検査ための血液処理方法及び採血管
KR102319110B1 (ko) * 2021-07-12 2021-10-29 주식회사 이노스템바이오 세포성 바이오 의약품의 장기 보존을 위한 동결보존액 조성물
WO2025106654A1 (en) * 2023-11-14 2025-05-22 The Children's Medical Center Corporation Methods of vascular cell therapy and endothelial cell engraftment via mitophagy inducers
KR102870918B1 (ko) * 2024-01-23 2025-10-14 주식회사 이에이치엘바이오 소변 내 세포의 보존을 위한 소변 중화액 조성물 및 이를 이용한 소변 중화 처리방법
CN120459380B (zh) * 2025-06-20 2025-11-14 安徽脉欣医疗科技有限公司 一种含静脉瓣的生物源性静脉的制备方法

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US716246A (en) 1902-03-24 1902-12-16 Fletcher Raymond Excavating apparatus.
US872525A (en) 1905-02-27 1907-12-03 Henry F Loewer Last.
DE4427299A1 (de) * 1994-08-02 1996-02-08 Faber Castell A W Beize und Verfahren zum Färben von Holz
EP1281357A3 (en) * 1997-09-26 2003-07-09 Duke University Perfusion-occlusion catheter and methods
SE9904652D0 (sv) * 1999-12-17 1999-12-17 Astra Pharma Prod Novel Compounds
US6608038B2 (en) * 2000-03-15 2003-08-19 Novartis Ag Methods and compositions for treatment of diabetes and related conditions via gene therapy
US20020182646A1 (en) 2001-04-30 2002-12-05 Ke Huazhu Methods and products for identifying modulators of P2X7 receptor activity, and their use in the treatment of skeletal disorders
US20130136725A1 (en) * 2002-06-19 2013-05-30 Nuevas Alternativas Naturales Thermafat, S.A.P.I. De C.V. Compositions for systemic treatment of pathological conditions resulting from oxidative stress and/or redox imbalance
GB0324498D0 (en) 2003-07-21 2003-11-26 Aventis Pharma Inc Heterocyclic compounds as P2X7 ion channel blockers
WO2005019182A1 (en) * 2003-08-20 2005-03-03 Bayer Healthcare Ag Pyrazolylmethylbenzamide derivatives as p2xt-receptor antagonists
SE0302488D0 (sv) * 2003-09-18 2003-09-18 Astrazeneca Ab New combination
US7241776B2 (en) * 2004-08-02 2007-07-10 Abbott Laboratories Cyanoamidine P2X7 antagonists for the treatment of pain
RU2410430C2 (ru) 2004-08-31 2011-01-27 Силентис С.А.У. Способы и композиции для ингибирования экспрессии рецептора p2х7
US8440610B2 (en) * 2004-11-12 2013-05-14 Massachusetts Institute Of Technology Mapkap kinase-2 as a specific target for blocking proliferation of P53-defective cells
CA2607541A1 (en) * 2005-05-05 2006-12-28 Medicure International Inc. Inhibition of atp-mediated, p2x7 dependent pathways by pyridoxal-5-phosphaste and vitamin b6 related compounds
US20090220516A1 (en) 2005-06-22 2009-09-03 Alan Laties Neuroprotection of retinal ganglion cells
CN101304981A (zh) 2005-11-07 2008-11-12 艾博特公司 P2x7受体拮抗剂及使用方法
US20070122849A1 (en) 2005-11-29 2007-05-31 Peekhaus Norbert T Rhesus monkey P2X7 purinergic receptor and uses thereof
US7658706B2 (en) * 2005-12-05 2010-02-09 Rti Biologics, Inc. Vascular graft sterilization and decellularization
US7597496B2 (en) * 2006-05-16 2009-10-06 Dubinski Jonathan B Scent activated, memory enhancing memory stick system
US20090149524A1 (en) 2006-06-06 2009-06-11 Paul John Beswick N-(Phenylmethyl)-2-(1H-Pyrazol-4-yl) Acetamide Derivatives as P2X7 Antagonists for the Treatment of Pain, Inflammation and Neurodegeneration
GB0611154D0 (en) 2006-06-06 2006-07-19 Glaxo Group Ltd Novel receptor antagonists and their methods of use
EA016076B1 (ru) 2006-07-06 2012-01-30 Глэксо Груп Лимитед Замещенные n-фенилметил-5-оксопролин-2-амиды в качестве антагонистов р2х7-рецептора и способы их применения
WO2008027963A2 (en) 2006-08-31 2008-03-06 Horizon Therapeutics, Inc. Nsaid dose unit formulations with h2-receptor antagonists and methods of use
US8067550B2 (en) 2006-10-10 2011-11-29 Biosceptre International Limited Hybridomas producing antibodies against non functional P2X7 receptor
WO2008043146A1 (en) 2006-10-10 2008-04-17 Biosceptre International Limited Antibodies against non functional p2x7 receptor
US8141551B2 (en) * 2007-02-16 2012-03-27 Destal Industries, Inc. Mouthpiece and flow rate controller for intrapulmonary delivery devices
US20080221027A1 (en) * 2007-03-09 2008-09-11 The Regents Of The University Of California Composition and Methods for the Treatment of Duchene Muscular Dystrophy
PT2124944E (pt) * 2007-03-14 2012-05-17 Ranbaxy Lab Ltd Derivados de pirazolo[3,4-b]piridina como inibidores de fosfodiesterase
GB0705882D0 (en) 2007-03-27 2007-05-02 Glaxo Group Ltd Novel compounds
JP2010522711A (ja) 2007-03-28 2010-07-08 グラクソ グループ リミテッド Ｐ２ｘ７調節因子としてのピペリジノンカルボキサミド誘導体
EP2139875A2 (en) 2007-03-29 2010-01-06 Glaxo Group Limited Oxazolidine and morpholine carboxamide derivatives as p2x7 modulators
MX2009010759A (es) 2007-04-03 2009-10-28 Glaxo Group Ltd Derivados de carboxamida imidazolidina como modulares de p2x7.
EP2150535A2 (en) 2007-04-11 2010-02-10 Glaxo Group Limited Pyrazole derivatives as p2x7 modulators
CA2699631A1 (en) 2007-10-31 2009-05-07 Nissan Chemical Industries, Ltd. Pyridazinone compounds and p2x7 receptor inhibitors
JP2011506554A (ja) 2007-12-18 2011-03-03 グラクソ グループ リミテッド Ｐ２ｘ７調節因子としての５−オキソ−３−ピロリジンカルボキサミド誘導体
GB0724625D0 (en) 2007-12-18 2008-01-30 Glaxo Group Ltd Novel compounds
CA2656577A1 (en) * 2008-04-14 2009-10-14 The University Of British Columbia Method for evaluation of a cancer
US8846068B2 (en) * 2008-04-18 2014-09-30 Warsaw Orthopedic, Inc. Methods and compositions for treating post-operative pain comprising a local anesthetic
EP2319873A4 (en) * 2008-06-23 2011-06-22 Guangzhou Konzern Pharmaceutical Co Ltd DEXTRAN TO TREAT LUNG CANCER
EP2393781B1 (en) 2008-12-23 2014-03-12 F. Hoffmann-La Roche AG Dihydropyridone ureas as p2x7 modulators
BRPI0923488A2 (pt) 2008-12-23 2019-09-24 Hoffmann La Roche amidas de didropiridona como modulares p2x7
JP5478637B2 (ja) 2008-12-23 2014-04-23 エフ．ホフマン−ラ ロシュ アーゲー Ｐ２ｘ７モジュレーターとしてのジヒドロピリドンアミド
CA2745952A1 (en) 2008-12-23 2010-07-01 F.Hoffmann-La Roche Ag Dihydropyridone amides as p2x7 modulators
US8153808B2 (en) 2008-12-23 2012-04-10 Roche Palo Alto Llc Dihydropyridone amides as P2X7 modulators
BR102012009350B1 (pt) * 2012-04-20 2020-12-29 Biolab Sanus Farmacêutica Ltda composição farmacêutica tópica, processo de produção da composição farmacêutica tópica e uso da composição farmacêutica tópica

Also Published As

Publication number Publication date
AU2010328203B2 (en) 2014-05-15
WO2011072012A2 (en) 2011-06-16
SG182261A1 (en) 2012-08-30
CN102834102A (zh) 2012-12-19
CN104623665A (zh) 2015-05-20
US20140220547A1 (en) 2014-08-07
CN102834102B (zh) 2015-01-14
CA2783236A1 (en) 2011-06-16
JP6203223B2 (ja) 2017-09-27
US10531654B2 (en) 2020-01-14
EP2848256B1 (en) 2018-11-14
WO2011072012A3 (en) 2011-09-09
US20110190572A1 (en) 2011-08-04
EP2509609B1 (en) 2014-10-01
ES2710522T3 (es) 2019-04-25
US10149470B2 (en) 2018-12-11
US20170071192A1 (en) 2017-03-16
EP2848256A2 (en) 2015-03-18
DK2848256T3 (da) 2019-03-04
EP2509609A2 (en) 2012-10-17
AU2010328203A1 (en) 2012-07-05
HK1210703A1 (en) 2016-05-06
JP2013512968A (ja) 2013-04-18
ES2524549T3 (es) 2014-12-10
US8691556B2 (en) 2014-04-08
EP2848256A3 (en) 2015-09-30
JP5819846B2 (ja) 2015-11-24
CA2783236C (en) 2020-03-10
CN104623665B (zh) 2018-01-12
HK1178804A1 (en) 2013-09-19
JP2016094386A (ja) 2016-05-26

Similar Documents

Publication Publication Date Title
DK3266463T3 (da) Hæmoglobinsammensætninger
DK3311823T3 (da) Fremgangsmåder og sammensætninger til brydning af biofilm ved hjælp af chitosan-derivatsammensætninger
DK3078664T3 (da) Antiparasitiske dihydroazol-sammensætninger
EP2350274A4 (en) CELL TRANSPLANTATION
EP2488022A4 (en) Compositions
DK3572100T3 (da) Sammensætning til stimulering af epitelcellevækst
BRPI1013829A2 (pt) composições e métodos para fermentação de biomassa
BRPI0924142A2 (pt) colheitadeiras combinadas
UY33161A (es) Composiciones plaguicidas
FR2947716B1 (fr) Implant prothetique ameliore
DK2504353T4 (da) Lipopeptidsammensætninger og tilsvarende fremgangsmåder
EP2419049A4 (en) TRANSPLANTATION DEVICE
BRPI1010690A2 (pt) composições
DK2513193T3 (da) Forbedrede blends af polyarylenethere og polyarylensulfider
DK2403814T3 (da) Landbrugsmæssig sammensætning
BR112012003320A2 (pt) ceifeira combinada
BRPI1011397A2 (pt) atenuador
BRPI0907462A2 (pt) Preparação de ilha pancreática e transplante
DK2473507T3 (da) Stabile sns-595-sammensætninger og fremgangsmåder til fremstilling
EP2484354A4 (en) ANTIOXIDANT COMPOSITION
BRPI1008494A2 (pt) Composições agrícolas
PL2243359T3 (pl) Sposób opóźniania dojrzewania zbiorów
BR112012002281A2 (pt) composicoes poliofinicas
DK2421388T3 (da) Fødevare-mellemprodukt
EP2440060A4 (en) FUNGICIDE COMPOSITION